The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global 3D printing in healthcare market size reached US$ 2.08 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.59 Billion by 2027, exhibiting a growth rate (CAGR) of 16.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Three-dimensional (3D) printing is employed in the healthcare sector to develop new surgical cutting, drill guides and prosthetics and create patient-specific replicas of bones, organs and blood vessels. It is used to make living human cells or tissue in regenerative medicine and tissue engineering. It assists in the customization and personalization of medical products, drugs and equipment. It also aids in reducing the operative risks involved during complex procedures, minimizes susceptibility to infections, and decreases the duration of anesthesia exposure. Besides this, it helps save time, reduces costs, and ensures faster and effective delivery of medical services. As a result, 3D printing is gaining immense traction in the healthcare industry across the globe.
The growing global geriatric population and the rising prevalence of chronic medical disorders, such as cancer and respiratory and cardiovascular disorders (CVDs), represent one of the key factors positively influencing the market. This, along with the rising requirement for regenerative medicines, stem cell solutions, and cancer therapeutics, is creating a positive market outlook. 3D printing finds extensive applications in liver modeling and the development of tissue, bone, and medical implants. In line with this, a significant rise in pharmaceutical applications and the availability of bioprinting tissues and organs are offering a favorable market outlook. Moreover, the rising focus of manufacturers on marketing strategies and promotional campaigns is contributing to the market growth. Furthermore, technological advancements in 3D printing, customization, and personalization are strengthening the growth of the market. Additionally, increasing investments by leading market players in research and development (R&D) activities for the advancement of 3D printers are anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D printing in healthcare market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on material, technology, application and end user.
Breakup by Material:
Breakup by Technology:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3D Systems Inc., Desktop Metal Inc., EOS GmbH, Formlabs, Materialise NV, Organovo Holding Inc., Oxford Performance Materials Inc., Prodways Tech, Proto Labs Inc., Renishaw plc, SLM Solutions Group AG and Stratasys Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Material, Technology, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3D Systems Inc., Desktop Metal Inc., EOS GmbH, Formlabs, Materialise NV, Organovo Holding Inc., Oxford Performance Materials Inc., Prodways Tech, Proto Labs Inc., Renishaw plc, SLM Solutions Group AG and Stratasys Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at